Search Ontology:
ChEBI
linsitinib
- Term ID
- CHEBI:91402
- Synonyms
-
- ASP-7487
- cis-3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol
- cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol
- linsitinib
- linsitinibum
- OSI 906
- OSI 906AA
- OSI-906
- OSI-906AA
- OSI906
- Definition
- An imidazopyrazine that is imidazo[1,5-a]pyrazine substituted by 2-phenylquinolin-7-yl, cis-3-hydroxy-3-methylcyclobutyl, and amino groups at positions 1, 3, and 8, respectively. It is dual inhibitor of the IGF-1 receptor and insulin receptor (IC50 = 35 and 75 nM, respectively) that was previously in clinical development for the treatment of cancer and thyroid eye disease.
- References
-
- CAS:867160-71-2
- DrugBank:DB06075
- HMDB:HMDB0254107
- KEGG:D09925
- LINCS:LSM-1135
- PMCID:PMC10555290
- PMID:20530704
- PMID:24726739
- PMID:25335932
- PMID:25795408
- PMID:26831715
- PMID:27686971
- PMID:27694157
- PMID:27849005
- PMID:28646158
- PMID:28772281
- PMID:29476383
- PMID:30139840
- PMID:31042587
- PMID:31433065
- PMID:31792037
- PMID:31897526
- PMID:33105604
- PMID:33322337
- PMID:33509009
- PMID:34071893
- PMID:34110249
- PMID:34982265
- PMID:36048501
- PMID:36415951
- PMID:37094617
- PMID:37435490
- PMID:37725888
- PMID:37810891
- Patent:EP2427192
- Patent:WO2011163430
- Wikipedia:Linsitinib
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from linsitinib
Phenotype where environments contain linsitinib
Phenotype modified by environments containing linsitinib
Human Disease Model